Retraction notices

MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells

Type

Retraction

Notice date

1/27/2021 0:00

Journal

RSC Advances

Publisher

Royal Society of Chemistry (RSC)

Notice DOI

10.1039/d1ra90049h

Original paper DOI

10.1039/c8ra10224d

Reasons

• Author Unresponsive
• Concerns/Issues about Data
• Duplication of/in Image
• Investigation by Third Party
• Paper Mill

Matching venue names

Name match only, not an authoritative journal identifier.

• RSC Advances